Sunesis To Host Conference Call On March 13th To Discuss Fourth Quarter And Full-Year 2012 Financial Results And Recent Highlights

SOUTH SAN FRANCISCO, Calif., March 6, 2013 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that it will host a conference call on Wednesday, March 13th, 2013 at 11:00 a.m. Eastern Time to discuss corporate updates and financial results for the fourth quarter and year ended December 31, 2012.
Sunesis Pharmaceuticals, Inc. Logo
VALOR Logo

The call can be accessed by dialing (866) 383-8108 (U.S. and Canada) or (617) 597-5343 (international), and entering passcode 36968092.

To access the live audio webcast, or the subsequent archived recording, visit the "Investors and Media - Calendar of Events" section of the Sunesis website at www.sunesis.com . The webcast will be recorded and available for replay on the Company's website for two weeks.

About Sunesis Pharmaceuticals

Sunesis is a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. Sunesis has built a highly experienced cancer drug development organization committed to advancing its lead product candidate, vosaroxin, in multiple indications to improve the lives of people with cancer. For additional information on Sunesis, please visit http://www.sunesis.com .

SUNESIS and the logos are trademarks of Sunesis Pharmaceuticals, Inc.

The Sunesis Pharmaceuticals, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=8773

The VALOR logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=8774
CONTACT: Investor and Media Inquiries:         David Pitts         Argot Partners         212-600-1902                  Eric Bjerkholt         Sunesis Pharmaceuticals Inc.         650-266-3717

Sunesis Pharmaceuticals, Inc. Logo

If you liked this article you might like

Cyclacel Stock Runs on Momentum Rocket Fueled by 'Dumb & Dumber' Optimism

Cyclacel Stock Runs on Momentum Rocket Fueled by 'Dumb & Dumber' Optimism

Insider Trading Alert - PODD, POWI And SNSS Traded By Insiders

Insider Trading Alert - PODD, POWI And SNSS Traded By Insiders

5 Stocks Under $10 Set to Soar

5 Stocks Under $10 Set to Soar

4 Biotech Stocks Under $10 to Trade for Breakouts

4 Biotech Stocks Under $10 to Trade for Breakouts

Analysts' Actions -- Cigna, Monster Beverage, Qualcomm and More

Analysts' Actions -- Cigna, Monster Beverage, Qualcomm and More